2018
DOI: 10.17826/cumj.394448
|View full text |Cite
|
Sign up to set email alerts
|

Effect of endocervical glandular involvement on residual and recurrent disease in patients with high grade cervical dysplasia

Abstract: The aim of this study was to evaluate the effect of endocervical glandular involvement on residual and recurrent disease in high-grade cervical dysplasia. Material and Methods: Patients underwent Loop Electrosurgical Excision Procedure (LEEP) or Cold Knife Conization (CKC) between January 2015 and June 2016 were identified. Patients that had low grade lesions in conization specimens were excluded. The data were collected for age, menopausal status, cytology, colposcopic findings, conization procedure, HPV posi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
(16 reference statements)
0
1
0
Order By: Relevance
“…Even though HPV-16 is reported to be significantly more common in patients with positive glandular involvement, HPV-16 was found to be the most common HPV genotype in cases with negative (65%) and positive (64.4%) endocervical glandular involvement, and there was no difference between the two groups in our study. 30 Also, the distribution of HPV-18 and other high-risk-HPV genotypes was not different between the two study groups. However, the percentages of HPV-16 in CIN 1, 2, and 3 patients were 44.8%, 66.7%, and 69.9%, respectively; moreover, the frequency of HPV-16 was significantly higher in the high-grade cervical dysplasia cohort.…”
Section: Discussionmentioning
confidence: 79%
“…Even though HPV-16 is reported to be significantly more common in patients with positive glandular involvement, HPV-16 was found to be the most common HPV genotype in cases with negative (65%) and positive (64.4%) endocervical glandular involvement, and there was no difference between the two groups in our study. 30 Also, the distribution of HPV-18 and other high-risk-HPV genotypes was not different between the two study groups. However, the percentages of HPV-16 in CIN 1, 2, and 3 patients were 44.8%, 66.7%, and 69.9%, respectively; moreover, the frequency of HPV-16 was significantly higher in the high-grade cervical dysplasia cohort.…”
Section: Discussionmentioning
confidence: 79%